Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2019, Article ID 7396870, 6 pages
https://doi.org/10.1155/2019/7396870
Research Article

Concomitant Sjögren’s Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis

Department of Gastroenterology & Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China

Correspondence should be addressed to Li Yang; nc.ude.ucs@xh_ilgnay

Received 19 March 2019; Revised 13 May 2019; Accepted 22 May 2019; Published 2 June 2019

Academic Editor: Paolo Muratori

Copyright © 2019 Ping Ni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Tanaka, H. Takikawa, S. Mochida, K. Koike, H. Miwa, and T. Shimosegawa, “Changing nomenclature for pbc from “primary biliary cirrhosis” to “primary biliary cholangitis”,” Journal of Gastroenterology, vol. 51, no. 7, pp. 748-749, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Marshall and M. D. Kaplan, “Primary biliary cirrhosis,” The New England Journal of Medicine, vol. 335, no. 21, pp. 1570–1580, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Corpechot, Y. Chrétien, O. Chazouillères, and R. Poupon, “Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis,” Journal of Hepatology, vol. 53, no. 1, pp. 162–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. K. D. Lindor, M. E. Gershwin, R. Poupon, M. Kaplan, N. V. Bergasa, and E. J. Heathcote, “Primary biliary cirrhosis,” Hepatology, vol. 50, no. 1, pp. 291–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Fan, T. Wang, Y. Shen, X. Xi, and L. Yang, “Underestimated male prevalence of primary biliary cholangitis in China: Results of a 16-yr cohort study involving 769 patients,” Scientific Reports, vol. 7, no. 6560, 2017. View at Google Scholar · View at Scopus
  6. M. M. Kaplan and M. E. Gershwin, “Primary biliary cirrhosis,” The New England Journal of Medicine, vol. 353, no. 12, pp. 1261–1273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. European Association for the Study of the Liver, “The diagnosis and management of patients with primary biliary cholangitis,” Journal of Hepatology, vol. 67, pp. 145–172, 2017. View at Google Scholar
  8. R. E. Poupon, K. D. Lindor, K. Cauch-Dudek, E. R. Dickson, R. Poupon, and E. J. Heathcote, “Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis,” Gastroenterology, vol. 113, no. 3, pp. 884–890, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Tincani, L. Andreoli, I. Cavazzana et al., “Novel aspects of Sjögren's syndrome in 2012,” BMC Medicine, vol. 11, no. 93, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Floreani and N. Cazzagon, “PBC and related extrahepatic diseases,” Best Practice & Research Clinical Gastroenterology, vol. 34-35, pp. 49–54, 2018. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Floreani, I. Franceschet, N. Cazzagon et al., “Extrahepatic autoimmune conditions associated with primary biliary cirrhosis,” Clinical Reviews in Allergy & Immunology, vol. 48, no. 2-3, pp. 192–197, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Chen, Y. Tseng, C. Yang et al., “Increased risks of spontaneous bacterial peritonitis and interstitial lung disease in primary biliary cirrhosis patients with concomitant sjogren syndrome,” Medicine, vol. 95, no. 2, p. e2537, 2016. View at Publisher · View at Google Scholar
  13. C. H. Shiboski, S. C. Shiboski, R. Seror et al., “2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: A consensus and data-driven methodology involving three international patient cohorts,” Annals of the Rheumatic Diseases, vol. 76, no. 1, pp. 9–16, 2016. View at Publisher · View at Google Scholar
  14. C. Corpechot, O. Chazouillres, and R. Poupon, “Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome,” Journal of Hepatology, vol. 55, no. 6, pp. 1361–1367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Corpechot, L. Abenavoli, N. Rabahi et al., “Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis,” Hepatology, vol. 48, no. 3, pp. 871–877, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Kumagi, M. Guindi, S. E. Fischer et al., “Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis,” American Journal of Gastroenterology, vol. 105, no. 10, pp. 2186–2194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Parés, L. Caballería, and J. Rodés, “Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid,” Gastroenterology, vol. 130, no. 3, pp. 715–720, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. E. H. Rheumatology Department, “Primary Sjögren's syndrome,” Lupus, vol. 27, pp. 32–35, 2018. View at Publisher · View at Google Scholar
  19. S. Olmez, S. Sayar, U. Avcioglu et al., “The relationship between liver histology and noninvasive markers in primary biliary cirrhosis,” European Journal of Gastroenterology & Hepatology, vol. 28, no. 7, pp. 773–776, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. P. J. Trivedi, T. Bruns, A. Cheung et al., “Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response,” Journal of Hepatology, vol. 60, no. 6, pp. 1249–1258, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. J. S. Marco Carbone, “The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis,” HEPATOLOGY, vol. 63, pp. 930–950, 2016. View at Google Scholar
  22. W. J. Lammers, G. M. Hirschfield, C. Corpechot et al., “Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy,” Gastroenterology, vol. 149, no. 7, pp. 1804–1812, 2015. View at Publisher · View at Google Scholar · View at Scopus